Jane Street Portfolio holdings
Jane Street Group, founded in 2000 by Tim Reynolds, Rob Granieri, Marc Gerstein, and Michael Jenkins, is a New York City-based quantitative trading firm renowned for its technological prowess and collaborative problem-solving culture. Specializing in liquidity provision and market-making, it trades a vast array of financial products—including equities, bonds, options, and ETFs—across over 200 venues in 45 countries, handling trillions in securities annually. The firm, which employs over 2,600 people across offices in New York, London, Hong Kong, Amsterdam, Chicago, and Singapore, leverages advanced algorithms and a nearly 70-million-line OCaml codebase to dominate markets, notably ETFs, where it plays a critical role as an authorized participant. With net trading revenues exceeding $10 billion annually in recent years, including a record $10.6 billion in 2023, Jane Street has emerged as a secretive yet powerful force in global finance, outpacing traditional Wall Street giants like Goldman Sachs in trading profitability.
Top Buys
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$1.3B |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
+$962M |
| 3 |
iShares Floating Rate Bond ETF
FLOT
|
+$661M |
| 4 |
iShares MSCI United Kingdom ETF
EWU
|
+$619M |
| 5 |
iShares MSCI EAFE Value ETF
EFV
|
+$543M |
Top Sells
| 1 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$1.05B |
| 2 |
Vanguard Total International Stock ETF
VXUS
|
+$725M |
| 3 |
SPDR Gold Trust
GLD
|
+$643M |
| 4 |
Vanguard Total International Bond ETF
BNDX
|
+$639M |
| 5 |
Meta Platforms (Facebook)
META
|
+$530M |
Sector Composition
| 1 | Technology | 10.39% |
| 2 | Consumer Discretionary | 8.83% |
| 3 | Financials | 5.76% |
| 4 | Communication Services | 5.35% |
| 5 | Healthcare | 4.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
301
SPDR Nuveen ICE Short Term Municipal Bond ETF
SHM
$3.46B
| $27.2M | 0.01% |
572,632
+12,485
| +2% | +$594K |
|
302
WisdomTree Yield Enhanced US Aggregate Bond Fund
AGGY
$803M
| $27.2M | 0.01% |
621,724
+413,471
| +199% | +$18.1M |
|
303
Teva Pharmaceuticals
TEVA
$22.6B
| $27.2M | 0.01% |
3,068,749
+652,768
| +27% | +$5.78M |
|
304
Spotify
SPOT
$147B
| $27.1M | 0.01% |
203,011
+45,511
| +29% | +$6.08M |
|
305
Truist Financial
TFC
$58.3B
| $27.1M | 0.01% |
795,077
+292,406
| +58% | +$9.97M |
|
306
iShares 1-3 Year International Treasury Bond ETF
IGOV
$1.12B
| $27M | 0.01% |
672,399
-435,134
| -39% | -$17.5M |
|
|
YTPG
307
DELISTED
TPG Pace Beneficial II Corp.
YTPG
| $26.9M | 0.01% |
2,700,237
-416,366
| -13% | -$4.15M |
|
308
iShares Agency Bond ETF
AGZ
$618M
| $26.9M | 0.01% |
248,700
+200,512
| +416% | +$21.7M |
|
309
KLA
KLAC
$122B
| $26.8M | 0.01% |
67,139
+29,344
| +78% | +$11.7M |
|
310
Magnolia Oil & Gas
MGY
$4.39B
| $26.7M | 0.01% |
1,218,650
+1,209,035
| +12,574% | +$26.5M |
|
311
iShares Exponential Technologies ETF
XT
$3.57B
| $26.6M | 0.01% |
504,209
+161,945
| +47% | +$8.53M |
|
312
Nice
NICE
$8.85B
| $26.3M | 0.01% |
114,896
+69,526
| +153% | +$15.9M |
|
|
CCVI
313
DELISTED
Churchill Capital Corp VI
CCVI
| $26.3M | 0.01% |
2,599,307
-457,398
| -15% | -$4.62M |
|
314
Lattice Semiconductor
LSCC
$9.06B
| $26.3M | 0.01% |
275,057
+265,892
| +2,901% | +$25.4M |
|
315
Lam Research
LRCX
$134B
| $26.3M | 0.01% |
495,360
-716,730
| -59% | -$38M |
|
316
First Trust Preferred Securities and Income ETF
FPE
$6.16B
| $25.8M | 0.01% |
1,618,356
-6,266,759
| -79% | -$100M |
|
317
Rio Tinto
RIO
$101B
| $25.8M | 0.01% |
375,847
+352,504
| +1,510% | +$24.2M |
|
318
Thermo Fisher Scientific
TMO
$182B
| $25.7M | 0.01% |
44,658
-6,318
| -12% | -$3.64M |
|
319
Invesco China Technology ETF
CQQQ
$1.43B
| $25.7M | 0.01% |
551,738
+214,703
| +64% | +$10M |
|
320
Johnson & Johnson
JNJ
$423B
| $25.6M | 0.01% |
165,326
+42,622
| +35% | +$6.61M |
|
321
iShares JPMorgan EM Local Currency Bond ETF
LEMB
$394M
| $25.6M | 0.01% |
709,144
+222,489
| +46% | +$8.02M |
|
322
SPDR FTSE International Government Inflation-Protected Bond ETF
WIP
$341M
| $25.5M | 0.01% |
589,416
-2,050,586
| -78% | -$88.6M |
|
323
AbbVie
ABBV
$369B
| $25.4M | 0.01% |
159,570
-171,068
| -52% | -$27.3M |
|
324
Elanco Animal Health
ELAN
$9.36B
| $25.4M | 0.01% |
2,701,632
-2,486,675
| -48% | -$23.4M |
|
325
CVS Health
CVS
$92.3B
| $25.2M | 0.01% |
339,351
-208,287
| -38% | -$15.5M |
|